On Wednesday, December 3 CAC2 invited members Steve Crowley and Vickie Buenger to explain the unique opportunity CAC2 has to shape a national strategy for childhood cancer
On Wednesday, November 12, CAC2 had the privilege of hosting Jeffrey Skolnik, MD, US Medical Affairs Leader, Oncology, GlaxoSmithKline and Attending Physician, Children’s Hospital of
The Congressional Childhood Cancer Caucus Presents Pediatric Cancer: Major Advances, Major Challenges 5th Annual Childhood Cancer Caucus Friday, September 19, 2014 9:00 – 10:30 a.m.
On May 22, we were privileged to host Dr. Peter Adamson speaking on the history and outlook for NCI Funding and Danielle Leach providing an
CAC2 ADVOCACY CALL NOTES – TUESDAY, APRIL 8, 2014 12:00 NOON EDT The fourth CAC2 Advocacy call was held on Tuesday, April 8, 2014 at
CAC2 ADVOCACY CALL- Tuesday, April 8, 2014 12:00pm EST Dial-in Number: 605-781-1000, Participant Access Code: 630468# Agenda: Introduction/Roll call (12:00-12:03) CAC2 Mission & Purpose for
The next call of the Advocacy Track will be Tuesday, April 8, 12:00 noon – 1:00 p.m. EST. To register for the call, please send
Dr. Peter Adamson provided an overview and update of the Children’s Oncology Group’s Project: EveryChild. He shared his slide deck below. Thank you for participating
The September Study Group will host a full-membership call on February 20th, from Noon – 1:00 ET. The September Study Group has been researching and
There will be a meeting next week at the National Cancer Institute (NCI) dedicated to pediatric cancer drug development. The National Cancer Institute (NCI) will
Join the coalition
